Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

755796

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his Department spends per capita on mental health per year in (a) England and (b) York.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	7118
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>The information requested is shown in the following table for the most recent year available.</p><p> </p><p>Expenditure on mental health services for England and the Vale of York, 2015/16.</p><table><tbody><tr><td rowspan="3"><p> </p></td><td colspan="2"><p>2015/16</p></td></tr><tr><td><p>Total Spend</p></td><td><p>Spend per head</p></td></tr><tr><td><p>£000s</p></td><td><p>£</p></td></tr><tr><td><p>Vale of York</p></td><td><p>46,662</p></td><td><p>148.68</p></td></tr><tr><td><p>England</p></td><td><p>9,148,314</p></td><td><p>157.10</p></td></tr></tbody></table><p><br>Note: Figures do not include expenditure on specialised commissioning.</p><p>Source: NHS England, Mental Health Five Year Forward View Dashboard <a href="https://www.england.nhs.uk/mental-health/taskforce/imp/mh-dashboard/" target="_blank">https://www.england.nhs.uk/mental-health/taskforce/imp/mh-dashboard/</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 12/09/2017 14:10:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4471 label Biography information for Rachael Maskell

755797

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Respiratory System: Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the NHS has spent on respiratory medicines in each of the last five years.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	7167
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>The information requested is shown in the table below.</p><p> </p><p>Cost of respiratory medicines to the National Health Service, by primary and secondary care, in England from years 2012 to 2016</p><table><tbody><tr><td><p> </p></td><td><p>Primary Care Net Ingredient Cost (£)</p></td><td><p>Secondary Care Cost (£)</p></td><td><p>Total Cost (£)</p></td></tr><tr><td><p>2012</p></td><td><p>1,009,505,840</p></td><td><p>39,842,049</p></td><td><p>1,049,347,889</p></td></tr><tr><td><p>2013</p></td><td><p>1,020,038,047</p></td><td><p>39,938,913</p></td><td><p>1,059,976,960</p></td></tr><tr><td><p>2014</p></td><td><p>1,032,783,044</p></td><td><p>38,983,420</p></td><td><p>1,071,766,464</p></td></tr><tr><td><p>2015</p></td><td><p>1,044,951,211</p></td><td><p>38,600,943</p></td><td><p>1,083,552,154</p></td></tr><tr><td><p>2016</p></td><td><p>1,034,877,082</p></td><td><p>38,547,801</p></td><td><p>1,073,424,883</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis; 2016 QuintilesIMS: Hospital Pharmacy Audit Index</p><p> </p><p>These figures do not include costs for treating respiratory infections or cancers, as the medicines required (antibiotics and chemotherapy) are used for other therapy areas and are not specific to respiratory disease. These costs are at list prices and discounts achieved by hospitals and community pharmacy have not been included.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2017 16:00:35 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

755798

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Professions: Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many applications there have been for entry to 2017-18 degree courses for (a) physiotherapy, (b) midwifery, (c) occupational therapy,(d) speech and language therapy, (e) dietetics, (f) podiatry, (g) diagnostic radiography, (h) therapeutic radiography, (i) paramedic science, (j) prosthetics and orthotics, (k) orthoptics, (l) art therapy, (m) drama therapy and (n) music therapy.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	7168
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>The Department is not responsible for collecting data on the number of applications to study degree courses in allied health profession subjects.</p><p> </p><p>The Universities and Colleges Admissions Service publishes data on the number of applications to full-time undergraduate courses. Further information is available at:</p><p><a href="https://www.ucas.com/corporate/data-and-analysis/ucas-undergraduate-releases/2017-cycle-applicant-figures-june-deadline-0" target="_blank">https://www.ucas.com/corporate/data-and-analysis/ucas-undergraduate-releases/2017-cycle-applicant-figures-june-deadline-0</a></p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 12/09/2017 14:10:02 answering member 1542 label Biography information for Philip Dunne
tabling member	151 label Biography information for Tom Brake

755799

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps are being taken to improve definitions of myalgic encephalomyelitis for diagnosis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7179
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7180 7181 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755800

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what training is provided for doctors to help them treat patients with myalgic encephalomyelitis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7180
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7181 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755801

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients received NHS treatment for myalgic encephalomyelitis in the last 12 months.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7181
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7180 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755802

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding is provided each year for research into myalgic encephalomyelitis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7182
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>The Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including myalgic encephalomyelitis (ME); it is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity. Currently, the NIHR is funding one project on ME; a large randomised controlled trial of an internet-based cognitive behavioural therapy for children aged 11-17 years. It is being led by Professor Esther Crawley at Bristol University and is funded for £994,430. It began in May 2016 and further information on this, and all NIHR funded projects, can be found at:</p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/hta/14192109/#/summary-of-research" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/hta/14192109/#/summary-of-research</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 12/09/2017 15:04:03 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1566 label Biography information for Daniel Kawczynski

755803

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many (a) parents and (b) children have received treatments under the £290 million funding announced in January 2016 for perinatal mental health.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	7137
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>In January 2016 the Government set out that an additional £290 million would be made available over the next five years to 2020/21 to invest in perinatal mental health services. A full breakdown of the allocations is not currently available.</p><p> </p><p>The Department does not hold data on the number of parents or children who received treatments under the £290 million made available for perinatal mental health.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 7136 question first answered 12/09/2017 14:28:31 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	478 label Biography information for Lord Field of Birkenhead

755804

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much of the £290 million funding announced in January 2016 for perinatal mental health has been allocated; and if he will provide a full breakdown of the allocations from that fund made to date.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	7136
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>In January 2016 the Government set out that an additional £290 million would be made available over the next five years to 2020/21 to invest in perinatal mental health services. A full breakdown of the allocations is not currently available.</p><p> </p><p>The Department does not hold data on the number of parents or children who received treatments under the £290 million made available for perinatal mental health.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 7137 question first answered 12/09/2017 14:28:31 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	478 label Biography information for Lord Field of Birkenhead

755805

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Psychiatric Nurses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the recommended caseload for a community psychiatric nurse is.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	7150
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>There is no standard recommended community psychiatric nurse caseload. An appropriate maximum caseload would depend upon the individual community psychiatric nurse’s casemix and the associated level of need, risk and complexity.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 12/09/2017 14:56:36 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4471 label Biography information for Rachael Maskell